Live Analyst Rating Changes 2092 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Young Li
JEF
Young Li
Wall Street Analyst
★☆☆☆☆
#2339
on 13Foresight · ranked by our own returns
33%
Success Rate
-13.2%
Average Return
4 of 12 calls profitable · -276.8% vs benchmark
📈 Across the calls we could measure, roughly 33% of Young Li's ratings turned a profit when each position was held for 1 year — averaging -13.2% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

4 Buy 2 Hold 0 Sell
Young's Stock Coverage 14 ratings · 2026-06-23
Company Date Position Consensus Price Target 1-Yr Return
ARAY
Accuray
May 12, 2026 HOLD Buy
+1755.0% avg upside
9 analysts
$0.35
11.85% Upside
·
TMDX
TransMedics Group
Oct 28, 2025 BUY Strong Buy
+55.0% avg upside
15 analysts
$145.00
92.09% Upside
-39.3%
CH:ALC
Alcon
Aug 06, 2025 BUY Buy
+34.6% avg upside
35 analysts
$92.96
74.29% Upside
·
RXST
RxSight
Jul 10, 2025 HOLD Hold
+126.0% avg upside
13 analysts
$9.00
81.54% Upside
-29.1%
ENOV
Enovis
May 30, 2025 BUY Strong Buy
+222.1% avg upside
37 analysts
$60.00
181.71% Upside
-20.5%
COO
Cooper Co
Apr 13, 2025 BUY Strong Buy
+103.1% avg upside
21 analysts
$105.00
60.43% Upside
-9.0%
HYPR
Hyperfine
Mar 18, 2025 HOLD Strong Buy
+30.9% avg upside
6 analysts
$1.20
19.51% Downside
+39.2%
STAA
Staar Surgical
Feb 12, 2025 HOLD Hold
+15.0% avg upside
16 analysts
$18.00
37.55% Downside
+0.1%
ATEC
Alphatec Holdings
Jan 14, 2025 BUY Strong Buy
+115.5% avg upside
22 analysts
$19.00
122.27% Upside
+43.4%
BLCO
Bausch + Lomb Corporation
May 06, 2024 BUY Buy
+30.4% avg upside
19 analysts
$25.00
67.43% Upside
-24.5%
SIBN
SI-Bone
Mar 11, 2024 BUY Strong Buy
+60.0% avg upside
18 analysts
$30.00
89.65% Upside
-12.8%
VREX
Varex Imaging
May 23, 2023 HOLD Strong Buy
+93.2% avg upside
9 analysts
$24.00
130.78% Upside
-32.3%
VRAYQ
Viewray
Apr 16, 2023 HOLD Strong Buy
+558333233.3% avg upside
12 analysts
$1.25
124999899.93% Upside
-100.0%
CNMD
Conmed
Oct 11, 2022 HOLD Hold
+82.3% avg upside
12 analysts
$85.00
161.22% Upside
+26.6%
🔒 9 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Young Li — Frequently Asked Questions
How accurate are Young Li's stock ratings?
Based on the calls 13Foresight could measure, about 33% of Young's ratings were profitable over a one-year hold, with an average return of -13.2% per rating, or -276.8% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Young ranked on 13Foresight?
Young Li is currently ranked #2339 with a 1-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Young cover?
Young most recently has ratings on ARAY, TMDX, CH:ALC, RXST, ENOV, COO, HYPR, STAA, ATEC, BLCO, SIBN, VREX and 2 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.